007575.KO Ilyang Pharmaceutical Co.,Ltd

Healthcare Pharmaceuticals Korea Stock Exchange
17,596 KRW
Close of Nov 4, 2026
6,350 15,260
Market cap
KRW 320B
P/E
-
P/B
-
ROE
11.4%
Dividend yield
0.90%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 007575.KO undervalued?

Graham number

The Graham number of Ilyang Pharmaceutical Co.,Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ilyang Pharmaceutical Co.,Ltd fundamental analysis

No fundamental analysis for Ilyang Pharmaceutical Co.,Ltd yet.

Ilyang Pharmaceutical Co.,Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ilyang Pharmaceutical Co.,Ltd

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and…

Full company profile